Precision

Precision neuroscience starts and ends with patients – people living with neurological diseases. Our goal is to develop novel, life-changing medicines that restore cognitive and motor function.

Our Approach

Cadent leverages recent advances in scientific understanding, translational biomarker research and emerging innovations in clinical endpoints, to design novel medicines and focused clinical studies –with the goal of expediting the delivery of new therapeutic options to patients.

patient selection

Patient

selection

Use of genetics, translational biomarkers and other measures to carefully select patients

Target Specificity

Target

Specificity

Selection of distinct, validated targets that can be modulated with high specificity

Drug design and optimization

Drug design

& optimization

Design of novel compounds to maximize benefit and minimize adverse effects

Quantitative

endpoints

Deploying novel insights to improve the precision of clinical endpoints